SGRY (Surgery Partners, Inc. Common Stock) Stock Analysis - News
Surgery Partners, Inc. Common Stock (SGRY) is a publicly traded Healthcare sector company. As of May 20, 2026, SGRY trades at $13.52 with a market cap of $1.82B and a P/E ratio of -23.18. SGRY moved -1.46% today. Year to date, SGRY is -12.06%; over the trailing twelve months it is -41.85%. Its 52-week range spans $11.41 to $33.37. Analyst consensus is buy with an average price target of $19.75. Rallies surfaces SGRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in SGRY news today?
Surgery Partners Q1 Revenue Climbs 4.5% to $810.9M, EBITDA $102.3M: Surgery Partners reported first-quarter revenue of $810.9 million, a 4.5% year-over-year increase, with same-facility revenue up 4.4% and net loss of $35.9 million. Adjusted EBITDA reached $102.3 million, and the company reaffirmed full-year 2026 guidance of $3.35–$3.45 billion revenue and at least $530 million EBITDA.
Surgery Partners Q1 Revenue Climbs 4.5% to $810.9M, EBITDA $102.3M: Surgery Partners reported first-quarter revenue of $810.9 million, a 4.5% year-over-year increase, with same-facility revenue up 4.4% and net loss of $35.9 million. Adjusted EBITDA reached $102.3 million, and the company reaffirmed full-year 2026 guidance of $3.35–$3.45 billion revenue and at least $530 million EBITDA.
Does Rallies summarize SGRY news?
Yes. Rallies summarizes SGRY news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SGRY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SGRY. It does not provide personalized investment advice.
